PREVENT DIABETES Act
Introduced February 24, 2025 · Last action February 24, 2025
Plain English Summary
This bill allows virtual (online and telehealth) diabetes prevention program suppliers to participate in Medicare's Diabetes Prevention Program starting January 1, 2026 through December 31, 2030. It removes the requirement that beneficiaries and suppliers be in the same state and eliminates limits on how many times someone can enroll in the program.
Who benefits
Virtual diabetes prevention program suppliers (telehealth companies, digital health platforms, and online fitness/nutrition coaching providers that meet CDC Diabetes Prevention Recognition Program standards); Medicare beneficiaries in rural or medically underserved areas who lack local access to in-person diabetes prevention programs; beneficiaries who can be treated multiple times without re-enrolling in new programs; telehealth technology vendors serving diabetes prevention.
Who pays / loses
Medicare trust funds bear the cost of expanded virtual MDPP coverage; traditional in-person diabetes prevention suppliers may experience reduced patient volume in markets where virtual alternatives compete; traditional community health centers and YMCAs offering in-person programs may face reduced referrals.
Funding & Lobbying Interests
Digital health and telehealth companies with diabetes prevention offerings stand to benefit from expanded Medicare reimbursement eligibility; venture-backed telehealth platforms serving chronic disease management; companies holding CDC Diabetes Prevention Recognition Program certification (e.g., health coaching platforms, digital behavioral health vendors). Sponsors include Representatives Diana DeGette (D-CO), Gus Bilirakis (R-FL), Jason Crow (D-CO), and Kim Schrier (D-WA), reflecting geographic and bipartisan support but no donor finance data provided in bill text.
Political Impact
Affected Groups
Medicare beneficiaries with prediabetes or diabetes (approximately 11 million beneficiaries have diagnosed diabetes per CMS data); rural Medicare beneficiaries (approximately 7-8 million) who lack local in-person diabetes prevention programs; beneficiaries in health professional shortage areas; seniors with mobility or transportation barriers to in-person programs.
Political Subtext
Proponents argue this expands access to evidence-based diabetes prevention, reduces travel burdens on seniors, and leverages proven digital health technology to reach underserved populations. They cite the chronic disease pandemic and primary care shortages as justification. Critics note this removes geographic oversight requirements that protect against fraud and low-quality virtual service delivery, that removing enrollment limits could lead to overutilization and cost-shifting, and that in-person community programs build social connection essential to long-term behavior change. The CDC's Diabetes Prevention Program shows in-person and virtual models have similar short-term outcomes (16% weight loss reduction in controlled trials), but limited long-term follow-up data exists on virtual-only, no-enrollment-limit models.
Real-World Stakes
If passed: Medicare will reimburse virtual-only diabetes prevention nationwide beginning January 2026, removing current geographic and state-licensing barriers. Beneficiaries may cycle through multiple enrollments seeking program credits or trying different vendors. Telehealth vendors will compete on price and convenience rather than physical presence. Administrative costs may decline (no facility overhead) but program monitoring and quality oversight become more difficult. Risk of 'diabetes prevention tourism' where beneficiaries enroll repeatedly for modest incentives. Historical precedent: Medicare's expansion of telehealth waivers during COVID-19 (March 2020-ongoing) showed rapid uptake and cost growth—beneficiary telehealth claims increased 38x within two months, though many services had lower costs than in-person care. The Veterans Health Administration's virtual Diabetes Prevention Program (launched 2021) reported 40% completion rates versus 65% for in-person cohorts. No non-partisan cost estimate (CBO analysis) is cited in the bill text.
What's Inside This Bill
Non-obvious provisions not apparent from the headline summary.
Removal of In-Person Verification Requirements
By allowing virtual-only participation without in-state requirements, the bill eliminates traditional identity verification and medical screening mechanisms that were previously conducted during in-person sessions, potentially allowing enrollment without direct clinical assessment.
AffectsMedicare beneficiaries with diabetes risk factors who may not meet clinical thresholds but enroll anyway; Medicare system exposed to potential fraud through unverified enrollments; clinical providers lose direct observation data for program effectiveness.
Unlimited Re-Enrollment Provision
The elimination of limits on how many times someone can enroll in the program removes a safeguard against repeated program cycles without demonstrated need or outcome measurement between enrollments.
AffectsBeneficiaries who could repeatedly enroll for the same or similar conditions, potentially leading to duplicative service billing; program administrators unable to track genuine prevention outcomes versus repeat participants; Medicare spending increases from multiple enrollments per beneficiary.
Sunset Clause with Specific Expiration
The program authorization expires December 31, 2030, creating a defined endpoint rather than permanent authority, requiring future Congressional action to continue virtual diabetes prevention services.
AffectsVirtual diabetes prevention program suppliers who must plan for potential service discontinuation; beneficiaries enrolled late in the period face uncertainty about continuing their programs; creates administrative burden for Medicare to transition back to previous models or require re-authorization.
State-Based Licensing Preemption Risk
Removing the same-state requirement may create conflicts with state telehealth licensing laws and scope-of-practice regulations that providers must follow, without explicit federal preemption language addressed in this summary.
AffectsHealthcare providers in states with strict telehealth licensing requirements who may operate outside regulatory compliance; beneficiaries in restrictive states may receive services from unlicensed providers by their state's standards; state medical boards' enforcement authority becomes unclear.
Sponsor
Co-sponsors (10)
RRep. Lawler, Michael [R-NY-17]RRep. Nunn, Zachary [R-IA-3]DRep. Suozzi, Thomas R. [D-NY-3]DRep. Walkinshaw, James R. [D-VA-11]RRep. Garbarino, Andrew R. [R-NY-2]DRep. Schrier, Kim [D-WA-8]RRep. Bilirakis, Gus M. [R-FL-12]DRep. Crow, Jason [D-CO-6]DRep. Goodlander, Maggie [D-NH-2]DRescom. Hernández, Pablo Jose [D-PR-At Large]
Vote Record
No recorded votes.
Campaign Finance — Primary Sponsor
Top contributing industries
Other$203,743.5
Healthcare$23,250
Law$6,000
Energy$3,300
Finance$2,000
501(c)(4) disclosure: Contributions from 501(c)(4) "dark money" organizations are not required to be publicly disclosed and are not reflected in the figures above. Data sourced from FEC public disclosure filings.
Community Discussion
Share this bill
Sign in to join the discussion.
No comments yet. Be the first.